7Baggers

Aurinia Pharmaceuticals Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -76.47-57.58-38.68-19.79-0.917.9936.8955.78Milllion

Aurinia Pharmaceuticals Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2001-08-31 2001-05-31 2001-02-28 2000-11-30 2000-08-31 2000-05-31 2000-02-29 1999-11-30 1999-08-31 1999-05-31 1999-02-28 
  revenue45,095,000 54,515,000 41,494,000 34,409,000 28,435,000 55,779,000 28,191,000 21,625,000 23,404,000 14,667,000 6,620,000 914,000 50,030,000 29,000 29,000 30,000 29,000 230,000 29,000 30,000 29,000 375,000 29,000 30,000 31,000 29,000 329,000 31,000 30,000 31,000 55,000 57,000 57,000 57,000 59,000 62,000 68,000 72,000 71,000 67,000 692,643.555 84,336.649 82,687.044 87,473.586 86,207.869 87,376.175 88,486.874 5,813,312.486 119,966.867 534,836.658 152,810.474 137,872.848 297,754.53 263,616.98 1,413,528.128 1,447,910.536 1,656,222.976 959,865.282 618,459.021 647,026.214 93,447.401 2,702,626.11 555,118.884 562,518.216 616,273.786 553,988.719 429,309.535 605,929.265 637,999.45 519,433.996 936,995.153 1,369,016.984 -1,130,630.576 1,763,213.349 204,074.969 317,434.075 255,476.054 262,450.543 255,033.154 467,503.546 615,631.476 306,914.071 6,529,421.372 215,972.421 300,445.58 4,188,903.941 5,456,643.587 2,202,645.934 522,691.928 522,269.629 447,750.509 299,185.224 249,175.074 66,740.081 275,660.552 488,370.362 200,729.317 271,280.239 397,746.105 
  cost of revenue5,395,000 6,769,000 1,563,000 421,000 1,362,000 2,447,000 1,599,000 256,000 481,000 254,000 308,000 48,000 13,173,000 4,800,000 13,835,000 13,292,000 17,791,000 11,152,000 10,631,000 10,839,000 11,152,000 10,504,000 8,887,000 1,000 1,000 1,000 1,000 1,000 2,000 1,000 4,000 5,000 8,000 11,000 10,000 8,000 939.17 982.849 6,614.977 9,144.018 10,815.062 19,043.61 13,579.436 11,564.036 15,487.548 155,364.18 9,317.098 8,722.621 4,743.383 27,467.138 38,875.575 44,905.978 236,874.973 -155,886.886 1,806,159.078 226,960.11 253,570.388 370,291.566 288,074.134 163,457.022 165,449.802 158,516.926 128,343.206 117,664.742 194,070.76 238,707.55 134,804.69 169,713.552 376,580.467 288,955.271 217,617.345 197,574.786 66,740.081 206,745.414 76,910.751 200,729.317 135,640.12 265,164.07 
  gross profit39,700,000 47,746,000 39,931,000 33,988,000 27,073,000 53,332,000 26,592,000 21,369,000 22,923,000 14,413,000 6,312,000 866,000 36,857,000 -4,771,000 29,000 -13,805,000 -13,263,000 -17,561,000 -11,123,000 -10,601,000 -10,810,000 -10,777,000 -10,475,000 -8,857,000 31,000 29,000 329,000 30,000 29,000 30,000 54,000 56,000 55,000 56,000 55,000 57,000 60,000 61,000 61,000 59,000 691,704.385 84,336.649 82,687.044 86,490.737 79,592.892 78,232.156 77,671.812 5,794,268.876 106,387.431 523,272.622 137,322.926 -17,491.332 288,437.432 254,894.359 1,408,784.745 1,420,443.398 1,617,347.402 914,959.304 381,584.048 647,026.214 249,334.286 896,467.032 328,158.774 308,947.829 245,982.22 265,914.585 265,852.513 605,929.265 472,549.647 360,917.07 808,651.948 1,369,016.984 -1,130,630.576 1,763,213.349 204,074.969 317,434.075 255,476.054 262,450.543 255,033.154 467,503.546 615,631.476 306,914.071 6,529,421.372 215,972.421 182,780.837 3,994,833.181 5,217,936.037 2,067,841.244 352,978.376 145,689.162 158,795.239 81,567.879 51,600.288 68,915.138 411,459.612 135,640.12 132,582.035 
  operating expenses                                                                                                   
  research and development10,228,000 13,605,000 12,650,000 13,158,000 9,870,000 10,973,000 11,525,000 12,620,000 11,149,000 20,066,000 10,091,000 9,833,000 13,173,000 4,800,000 11,076,000 13,835,000 13,292,000 17,791,000 11,152,000 10,631,000 10,839,000 11,152,000 10,504,000 8,887,000 8,691,000 10,807,000 7,107,000 7,325,000 5,462,000 3,342,000 2,406,000 3,324,000 3,652,000 4,670,000 4,330,000 3,330,000 3,092,000 2,433,000 2,547,000 1,040,000 640,589.005 527,346.401 429,592.457 332,203.057 3,301,711.617 562,865.126 803,264.182 803,840.795 939,625.388 742,989.303 1,115,103.457 803,572.347 968,427.413 671,641.791 970,496.158 1,391,014.322 2,159,982.3 1,720,460.286 1,387,656.66 1,916,528.075 1,093,374.127 2,944,454.94 3,950,677.933 3,709,317.012 7,622,121.932 6,661,966.156 8,259,276.656 5,644,070.735 4,714,138.119 5,014,329.214 4,818,704.003 4,278,606.965 4,522,691.155 5,079,774.653 4,993,306.341 4,403,571.133 5,490,337.936 4,923,921.059 1,177,653.095 1,789,936.09 3,150,076.126 1,967,947.817 1,952,515.999 1,898,104.621 -3,609,508.169 2,672,253.552 4,906,693.043 3,338,140.322 1,733,272.245 2,691,997.502 1,693,382.013 1,954,554.751 1,139,958.991 1,201,321.454 482,405.965 1,292,287.726 -200,729.317 339,100.299 
  sales, general and administrative                                                                                                   
  total operating expenses60,300,000 64,009,000 56,101,000 63,572,000 55,173,000 62,831,000 62,581,000 59,251,000 55,628,000 64,766,000 53,446,000 49,638,000 52,339,000 36,370,000 27,110,000 25,299,000 20,929,000 24,241,000 16,483,000 14,915,000 14,692,000 14,483,000 14,369,000 13,077,000 12,170,000 13,819,000 10,378,000 11,115,000 8,054,000 5,420,000 4,606,000 4,903,000 5,579,000 6,484,000 6,107,000 5,633,000 4,901,000 4,211,000 4,629,000 3,782,000 2,058,747.027 1,102,192.753 985,591.545 903,238.488 5,723,632.205 1,768,859.538 1,988,005.113 2,005,592.808 1,979,306.114 1,631,492.724 2,043,323.834 1,775,884.598 2,389,291.797 1,655,359.566 2,021,629.826 2,350,402.197 3,306,538.936 2,663,485.827 2,702,097.42 3,236,714.976 1,699,355.484 4,661,817.495 5,898,997.838 5,494,996.6 9,371,748.832 8,423,650.282 10,030,061.062 7,681,171.983 6,587,982.153 7,034,748.343 7,001,436.008 6,254,932.235 8,425,866.764 7,431,299.187 7,167,112.911 7,639,910.722 8,965,917.188 6,938,684.893 4,246,302.019 3,875,779.808 5,928,149.423 4,446,186.5 4,763,248.155 3,451,470.929 3,275,724.678 2,261,428.436 2,926,475.437 4,429,744.812 2,496,015.281 3,398,329.778 2,434,643.394 2,697,122.114 1,663,430.333 1,735,242.1 895,896.793 964,739.55 66,909.772 542,560.479 331,455.088 
  operating income-20,600,000 -16,263,000 -16,170,000 -29,584,000 -28,100,000 -9,499,000 -35,989,000 -37,882,000 -32,705,000 -50,353,000 -47,134,000 -50,543,000 -8,052,000 -36,341,000 -26,863,000 -25,269,000 -20,900,000 -24,011,000 -16,454,000 -14,885,000 -14,663,000 -14,108,000 -14,340,000 -13,047,000 -12,139,000 -13,790,000 -10,049,000 -11,085,000 -8,025,000 -5,390,000 -4,552,000 -4,847,000 -5,524,000 -6,428,000 -6,052,000 -5,576,000 -4,841,000 -4,210,000 -4,568,000 -3,723,000 -1,348,683.863 -1,017,856.104 -902,904.501 -816,747.752 -5,644,039.312 -1,690,627.381 -1,910,333.301 3,788,676.068 -1,872,918.684 -1,108,220.102 -1,906,000.909 -1,793,375.93 -2,094,070.105 -1,407,249.467 -612,845.081 -929,958.799 -1,710,168.708 -1,748,526.523 -2,320,513.373 -2,589,688.762 -2,191,188.002 -3,765,350.463 -5,570,839.065 -5,186,048.771 -9,125,766.612 -8,157,735.697 -9,764,208.549 -7,075,242.718 -6,115,432.505 -6,673,831.274 -6,192,784.06 -4,885,915.251 -9,556,497.34 -5,668,085.838 -6,963,037.942 -7,322,476.647 -8,710,441.134 -6,676,234.35 -3,991,268.865 -3,408,276.262 -5,312,517.947 -4,139,272.429 1,766,173.217 -3,235,498.508 -3,092,943.841 1,733,404.745 2,291,460.6 -2,361,903.568 -2,143,036.905 -3,252,640.616 -2,275,848.155 -2,615,554.234 -1,611,830.045 -1,735,242.1 -826,981.655 -553,279.939 -66,909.772 -406,920.359 -198,873.053 
  net income-26,875,000 -13,447,000 -11,492,000 -26,206,000 -26,046,000 -8,989,000 -35,515,000 -37,630,000 -33,322,000 -50,255,000 -47,010,000 -50,379,000 -8,074,000 -34,064,000 -29,526,000 -16,534,000 -76,469,000 -19,037,000 -15,901,000 -12,428,000 -14,593,000 -18,342,000 -15,707,000 -15,478,000 -3,332,000 -13,120,000 -2,399,000 -51,941,000 -8,333,000 -7,419,000 -3,276,000 -4,267,000 -3,937,000 -5,155,000 -733,000 -8,601,000 -4,919,000 -2,520,000 -4,017,000 -5,191,000 1,555,385.641 -2,152,038.62 -988,442.822 -779,399.479 -5,166,348.916 -1,729,235.458 -2,303,608.298 -455,042.046 -6,331,506.514 2,160,547.364 4,876,512.617 -2,976,613.061 -2,458,631.042 -1,502,229.114 -461,056.826 780,851.481 -1,608,793.333 -1,684,909.72 -406,563.59 -3,269,977.033 -2,198,509.807 -3,511,241.262 -5,336,018.864 -5,185,077.237 -8,602,493.136 -7,413,376.309 -9,322,686.707 -6,721,567.268 -5,818,755.332 -6,261,866.38 -5,982,767.905 -4,599,416.71 -9,415,855.217 -5,539,930.332 -6,520,603.409 -6,967,016.616 -8,710,150.195 -7,229,679.905 -3,410,693.39 -2,899,589.695 -6,757,589.683 -4,624,418.527 1,135,874.326 -4,049,653.218 -2,776,006.58 2,490,154.69 2,096,933.729 -2,073,484.231 -2,140,455.71 -3,104,349.862 -2,124,862.518 -2,441,345.505 -1,446,165.963 -1,668,502.019 -758,066.517 -887,828.8 66,909.772 -474,740.419 66,291.018 

We provide you with 20 years income statements for Aurinia Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Aurinia Pharmaceuticals stock. Explore the full financial landscape of Aurinia Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about Aurinia Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.